Terra Magnum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Terra magnum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Terra Magnum Today - Breaking & Trending Today

Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Development | Vaccines


Hits: 137
GAITHERSBURG, MD, USA and GUANGZHOU, China I April 21, 2021 I RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announced today execution of definitive agreements for a seed round financing of $10 million. RNAimmune is a spin-off entity from Sirnaomics, a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases. Smooth River and Hong Kong Hongrun led the investment, with participation from Shanghai Walga Biotechnology, High Forest Investment and Terra Magnum Sigma. Sirnaomics also increased its investment in RNAimmune. This financing will allow RNAimmune to accelerate its research and development into mRNA vaccine and drug discovery focused on infectious disease, cancer, and rare diseases. ....

United States , Hong Kong Hongrun , Los Angeles , Patrick Lu , University Of California , Rnaimmune Inc , I Rnaimmune Inc , Therapeutic Development , Drug Administration , Sirnaomics Inc , Sirnaomic Spin Off , Seed Financing , Based Vaccine , Chinai April , Shanghai Walga Biotechnology , High Forest Investment , Terra Magnum , Last August , Polypeptide Lipid Nanoparticle , Immune Therapy , Personalized Immunotherapy , Cancer Vaccine , ஒன்றுபட்டது மாநிலங்களில் , லாஸ் ஏஞ்சல்ஸ் , பேட்ரிக் லு , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா ,

RNAimmune Raises $10M in Seed Financing


RNAimmune Raises $10M in Seed Financing
RNAimmune, Inc., a Gaithersburg, MD-based biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, raised $10m in seed funding.
Smooth River and Hong Kong Hongrun led the investment, with participation from Shanghai Walga Biotechnology, High Forest Investment and Terra Magnum Sigma. RNAimmune is a spin-off entity from Sirnaomics, a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, who increased its investment in the company.
The company intends to use the funds to accelerate its research and development into mRNA vaccine and drug discovery focused on infectious disease, cancer, and rare diseases. ....

United States , Hong Kong Hongrun , Los Angeles , University Of California , Rnaimmune Inc , Drug Administration , Sirnaomics Inc , Shanghai Walga Biotechnology , High Forest Investment , Terra Magnum , Last August , Polypeptide Lipid Nanoparticle , ஒன்றுபட்டது மாநிலங்களில் , லாஸ் ஏஞ்சல்ஸ் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா , கடந்த ஆகஸ்ட் ,